1) ovarian cancer
卵巢癌
1.
Research progress in neoadjuvant chemotherapy for advanced ovarian cancer;
晚期卵巢癌新辅助化疗研究进展
2.
Effects of insulin-1ike growth factor 1 and its receptor on proliferation of ovarian cancer cells;
胰岛素样生长因子1及其受体在卵巢癌细胞增殖中的作用
3.
Proteomic pattern established with advanced ovarian cancer be used in diagnosis of early-stage ovarian cancer;
晚期卵巢癌的血浆蛋白质组学模型用于早期卵巢癌诊断的初步研究
2) Ovarian carcinoma
卵巢癌
1.
Ovarian carcinoma cells inhibit CD69 expression in CD8~+ T cells;
卵巢癌细胞对CD8~+ T细胞活化分子CD69表达的影响
2.
The clinical analysis of chemotherapy of taxol plus poldine for ovarian carcinoma;
含紫杉醇类和卡铂的不同方案治疗卵巢癌临床分析
3.
Effects of resveratrol on the expression of FAK and the level of phosphorylated FAK in highly metastatic ovarian carcinoma HO-8910PM cell line;
白藜芦醇对高转移卵巢癌细胞中FAK表达及磷酸化水平的影响
3) Ovary cancer
卵巢癌
1.
Establisment of BCRP expressing ovary cancer cell line 3AO/BCRP and its biological profile;
表达BCRP的卵巢癌耐药细胞系3AO/BCRP的建立及其生物学特征
2.
Treatment of 28 cases ovary cancer by chemotherapy in celiac autrum combined with venipuncture to hydrate;
腹腔化疗与静脉水化相结合治疗卵巢癌28例
3.
Clinical observation on the adhesion molecule expression and functional study of platelets in ovary cancer patients;
卵巢癌患者外周血血小板活化分子CD_(62)、CD_(63)含量的临床检测及意义
4) Ovarian tumor
卵巢癌
1.
Objective To study the effect of arsenic trioxide(As_(2)O_(3))on drug-resistant ovarian tumor cell strain COC1/DDP,and to investigate the mechanism of As_(2)O_(3) in inhibiting the growth of drug-resistant ovarian tumor cells.
目的研究三氧化二砷(As2O3)对卵巢癌耐顺铂细胞株COC1/DDP的作用,探讨As2O3抑制肿瘤细胞生长的作用机制。
2.
Methods Phosphatidic acid(LPA)(with biochemistry) and serum CA125(with CLIA) contents were determined in 30 patients with ovarian carcinoma,32 patients with benign ovarian tumor and 36 controls.
目的:探讨血浆溶血磷脂酸(LPA)水平的测定在卵巢癌患者诊断中的价值。
3.
Clinical significance of estimating blood serum CA125 for differential diagnosis of benign or malignant Ovarian Tumor;
结果49例卵巢癌中有40例(81。
5) Ovary carcinoma
卵巢癌
1.
Clinical significance of microalbuminuria/creatinine for earlier diagnosis of kidney lesion in patients with ovary carcinoma in union chemotherapy
尿微量白蛋白/肌酐在卵巢癌患者联合化疗中对肾脏损害的早期预警价值
2.
Objective: Our aim was to study the expressions of telomerase in ovary carcinoma and para - carcinoma tissues.
目的:探讨卵巢癌组织与癌旁组织端粒酶的表达情况。
补充资料：家族性卵巢癌
家族性卵巢癌
指同一家族中有两个或两个以上的一代血亲患卵巢癌。
说明：补充资料仅用于学习参考，请勿用于其它任何用途。
参考词条